LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Taxol | 0.0018 | 4.71 | 771.67 | 1034 | 956 | 1.0812 | 1.5734 | MN20160304_L01 | L06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 4.71 | 771.67 | 1034 | 956 | 1.0812 | 1.5734 | MN20160304_L01 | M11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.71 | 771.67 | 1034 | 956 | 1.0812 | 1.5734 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.94 | 771.67 | 1167 | 1045 | 1.1166 | 1.5733 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 6.94 | 771.67 | 1167 | 1045 | 1.1166 | 1.5733 | MN20160304_L01 | I16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.21 | 770.25 | 959 | 904 | 1.0601 | 1.5722 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 9.16 | 771.67 | 1311 | 1138 | 1.1515 | 1.5718 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 7.66 | 770.25 | 1235 | 1090 | 1.1330 | 1.5663 | MN20160304_L02 | N11 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.56234 | 4.71 | 771.67 | 1033 | 956 | 1.0801 | 1.5653 | MN20160304_L01 | L20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 2.49 | 771.67 | 905 | 867 | 1.0429 | 1.5636 | MN20160304_L01 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 5.6234 | 5.44 | 770.25 | 1117 | 1012 | 1.1029 | 1.5632 | MN20160304_L02 | M18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 5.44 | 770.25 | 1117 | 1012 | 1.1029 | 1.5632 | MN20160304_L02 | N12 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.031667 | 7.66 | 770.25 | 1234 | 1090 | 1.1321 | 1.5622 | MN20160304_L02 | M19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 9.16 | 771.67 | 1308 | 1138 | 1.1489 | 1.5613 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | 0 | 3.21 | 770.25 | 958 | 904 | 1.0590 | 1.5606 | MN20160304_L02 | K16 | |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 10.06 | 770.25 | 1434 | 1218 | 1.1769 | 1.5581 | MN20160304_L02 | J18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 11.56 | 771.67 | 1531 | 1280 | 1.1955 | 1.5536 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Vorinostat | 10 | 5.44 | 770.25 | 1115 | 1012 | 1.1010 | 1.5516 | MN20160304_L02 | L19 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 5.44 | 770.25 | 1115 | 1012 | 1.1010 | 1.5516 | MN20160304_L02 | L12 |
| MCF 10A-H2B-mCherry | Etoposide | 0.018333 | 4.71 | 771.67 | 1031 | 956 | 1.0780 | 1.5493 | MN20160304_L01 | C09 |
| MCF 10A-H2B-mCherry | Alpelisib | 5.6234 | 11.56 | 771.67 | 1529 | 1280 | 1.1939 | 1.5490 | MN20160304_L01 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.49 | 771.67 | 904 | 867 | 1.0418 | 1.5469 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.31623 | 2.49 | 771.67 | 904 | 867 | 1.0418 | 1.5469 | MN20160304_L01 | I07 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 5.44 | 770.25 | 1114 | 1012 | 1.1000 | 1.5458 | MN20160304_L02 | N11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 5.44 | 770.25 | 1114 | 1012 | 1.1000 | 1.5458 | MN20160304_L02 | I20 |